Quarterly report pursuant to Section 13 or 15(d)

Liquidity (Details Narrative)

v3.7.0.1
Liquidity (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended
May 31, 2017
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Mar. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash   $ 5,810,486 $ 6,618,921 $ 5,810,486 $ 6,618,921 $ 1,200,000 $ 3,476,880 $ 8,039,562
Working capital deficit   4,100,000   4,100,000   $ 9,600,000    
Net loss before taxes   1,626,573 1,256,156 4,274,216 3,196,962      
Depreciation and amortization expenses   1,453,145 $ 1,205,147 2,972,690 2,418,657      
Amount owed by company for acquisition   5,000,000   5,000,000        
Reduction in direct operating costs second quarter 2017 vs fourth quarter 2016   1,900,000            
Reduction in general and administrative second quarter 2017 vs fourth quarter 2016   $ 1,500,000            
Reduction in percentage of direct operating costs second quarter 2017 vs fourth quarter 2016   31.00%            
Reduction in percentage of general and administrative second quarter 2017 vs fourth quarter 2016   35.00%            
Positive cash from operations   $ 179,000   (688,885) (316,705)      
Net proceeds from issuance of common stock       2,000,000      
Improvement in cash used by operations from the first quarter   1,000,000            
MediGain [Member]                
Total purchase price of MediGain       7,000,000        
Credit Facility [Member] | Opus Bank [Member]                
Line of credit facility maximum borrowing capacity   10,000,000   10,000,000        
Repayment of term loan from equity financing       2,800,000        
Normal repayment of term loan       667,000        
Total line of credit owed   $ 5,200,000   $ 5,200,000        
Line of credit expire date       Sep. 01, 2018        
11% Series A Cumulative Redeemable Preferred Stock [Member]                
Number of stock shares issued during the period       295,000        
Shares issued price per share   $ 25.00   $ 25.00        
Net proceeds from issuance of preferred stock       $ 6,200,000        
Common Stock [Member]                
Number of stock shares issued during the period 1,000,000     1,000,000        
Shares issued price per share $ 2.30              
Net proceeds from issuance of common stock $ 2,000,000